newsfilter
← Latest News
GlobeNewswire·

MaxCyte Signs Platform License Agreement with Adicet Bio

MaxCyte's Flow Electroporation® technology and ExPERT™ platform to support development of Adicet's gamma delta T cell therapy gene edited programs ROCKVILLE, Md., Aug. 04, 2025 (GLOBE NEWSWIRE) -- MaxCyte,